↓ Skip to main content

Liquid biopsy: a step forward towards precision medicine in urologic malignancies

Overview of attention for article published in Molecular Cancer, April 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
25 X users
patent
1 patent
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
283 Dimensions

Readers on

mendeley
440 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
Published in
Molecular Cancer, April 2017
DOI 10.1186/s12943-017-0644-5
Pubmed ID
Authors

Ashley Di Meo, Jenni Bartlett, Yufeng Cheng, Maria D. Pasic, George M. Yousef

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 440 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 <1%
Unknown 439 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 64 15%
Student > Bachelor 61 14%
Researcher 52 12%
Student > Master 48 11%
Other 25 6%
Other 66 15%
Unknown 124 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 115 26%
Medicine and Dentistry 67 15%
Agricultural and Biological Sciences 44 10%
Engineering 15 3%
Chemistry 15 3%
Other 37 8%
Unknown 147 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2022.
All research outputs
#1,800,743
of 25,998,826 outputs
Outputs from Molecular Cancer
#105
of 1,960 outputs
Outputs of similar age
#33,709
of 327,182 outputs
Outputs of similar age from Molecular Cancer
#1
of 34 outputs
Altmetric has tracked 25,998,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,960 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.